跳至主要内容
临床试验/JPRN-UMIN000019206
JPRN-UMIN000019206已完成1 期

Exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intake - Phase I/II study of FOLFOX+IP PTX

The University of Tokyo0 个研究点目标入组 34 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) metastasis to distant organ sites other than the peritoneum, ovary or abdominal lymph nodes 2) other active concomitant malignancies 3) massive ascites which requires frequent drainage for palliation other severe medical conditions 4) contraindication for fluorouracil, levofolinate, oxaliplatin or paclitaxel 5) past or current severe heart disease 6) severe complications such as interstitial pneumonitis, pulmonary fibrosis, uncontrollable diabetes mellitus, renal failure or liver cirrhosis 7) pregnant or nursing women 8) judged to be unfit to participate in this study by investigators

研究者

相似试验